Post Wed Oct 23, 2019 3:31 pm

2019-Aghajani et al-Cancer Immunol Immunother

"Pembrolizumab for anaplastic thyroid cancer: a case study"
Aghajani MJ, Cooper A, McGuire H, Jeffries T, Saab J, Ismail K, de Souza P, Bray V, Fazekas de St Groth B, Niles N, Roberts TL
Cancer Immunol Immunother. 2019
https://doi.org/10.1007/s00262-019-02416-7

- no dataset accession number given